BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28986415)

  • 41. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study.
    Witt K; Daniels C; Reiff J; Krack P; Volkmann J; Pinsker MO; Krause M; Tronnier V; Kloss M; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    Lancet Neurol; 2008 Jul; 7(7):605-14. PubMed ID: 18538636
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microelectrode recording (MER) findings during sleep-awake anesthesia using dexmedetomidine in deep brain stimulation surgery for Parkinson's disease.
    Kwon WK; Kim JH; Lee JH; Lim BG; Lee IO; Koh SB; Kwon TH
    Clin Neurol Neurosurg; 2016 Apr; 143():27-33. PubMed ID: 26895206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Awake versus Asleep Anesthesia in Deep Brain Stimulation Surgery for Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Lim ML; Zhan ABB; Liu SJ; Saffari SE; Li W; Teo MM; Wong TG; Ng WH; Wan KR
    Stereotact Funct Neurosurg; 2024; 102(3):141-155. PubMed ID: 38636468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Deep brain stimulation of the subthalamic nucleus for parkinson's disease: awake vs asleep].
    Asriyants SV; Tomskiy AA; Gamaleya AA; Pronin IN
    Zh Vopr Neirokhir Im N N Burdenko; 2021; 85(5):117-121. PubMed ID: 34714012
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential effects of deep brain stimulation target on motor subtypes in Parkinson's disease.
    Katz M; Luciano MS; Carlson K; Luo P; Marks WJ; Larson PS; Starr PA; Follett KA; Weaver FM; Stern MB; Reda DJ; Ostrem JL;
    Ann Neurol; 2015 Apr; 77(4):710-9. PubMed ID: 25627340
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Socioeconomic Status May Impact Functional Outcome of Deep Brain Stimulation Surgery in Parkinson's Disease.
    Genc G; Abboud H; Oravivattanakul S; Alsallom F; Thompson NR; Cooper S; Gostkowski M; Machado A; Fernandez HH
    Neuromodulation; 2016 Jan; 19(1):25-30. PubMed ID: 26076401
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anesthesia for deep brain stimulation system implantation: adapted protocol for awake and asleep surgery using microelectrode recordings.
    Vesper J; Mainzer B; Senemmar F; Schnitzler A; Groiss SJ; Slotty PJ
    Acta Neurochir (Wien); 2022 Apr; 164(4):1175-1182. PubMed ID: 35212799
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
    Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
    Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advanced therapies in Parkinson's disease: Long-term retrospective study.
    Merola A; Espay AJ; Romagnolo A; Bernardini A; Rizzi L; Rosso M; Espay KJ; Zibetti M; Lanotte M; Lopiano L
    Parkinsonism Relat Disord; 2016 Aug; 29():104-8. PubMed ID: 27215392
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
    Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
    J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Beneficial effects of bilateral subthalamic stimulation on alexithymia in Parkinson's disease.
    Dafsari HS; Ray-Chaudhuri K; Mahlstedt P; Sachse L; Steffen JK; Petry-Schmelzer JN; Dembek TA; Reker P; Barbe MT; Visser-Vandewalle V; Fink GR; Timmermann L
    Eur J Neurol; 2019 Feb; 26(2):222-e17. PubMed ID: 30107062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's disease.
    Drapier S; Raoul S; Drapier D; Leray E; Lallement F; Rivier I; Sauleau P; Lajat Y; Edan G; Vérin M
    J Neurol; 2005 May; 252(5):583-8. PubMed ID: 15778909
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Impact of Pallidal and Subthalamic Deep Brain Stimulation on Urologic Function in Parkinson's Disease.
    Mock S; Osborn DJ; Brown ET; Stuart Reynolds W; Turchan M; Pallavaram S; Rodriguez W; Dmochowski R; Tolleson CM
    Neuromodulation; 2016 Oct; 19(7):717-723. PubMed ID: 27172446
    [TBL] [Abstract][Full Text] [Related]  

  • 55. STN versus GPi deep brain stimulation for dyskinesia improvement in advanced Parkinson's disease: A meta-analysis of randomized controlled trials.
    Zhang J; Li J; Chen F; Liu X; Jiang C; Hu X; Ma L; Xu Z
    Clin Neurol Neurosurg; 2021 Feb; 201():106450. PubMed ID: 33421741
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
    Dafsari HS; Martinez-Martin P; Rizos A; Trost M; Dos Santos Ghilardi MG; Reddy P; Sauerbier A; Petry-Schmelzer JN; Kramberger M; Borgemeester RWK; Barbe MT; Ashkan K; Silverdale M; Evans J; Odin P; Fonoff ET; Fink GR; Henriksen T; Ebersbach G; Pirtošek Z; Visser-Vandewalle V; Antonini A; Timmermann L; Ray Chaudhuri K;
    Mov Disord; 2019 Mar; 34(3):353-365. PubMed ID: 30719763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GPi vs STN deep brain stimulation for Parkinson disease: Three-year follow-up.
    Odekerken VJ; Boel JA; Schmand BA; de Haan RJ; Figee M; van den Munckhof P; Schuurman PR; de Bie RM;
    Neurology; 2016 Feb; 86(8):755-61. PubMed ID: 26819458
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson's disease.
    Evidente VG; Premkumar AP; Adler CH; Caviness JN; Driver-Dunckley E; Lyons MK
    Acta Neurol Scand; 2011 Sep; 124(3):211-4. PubMed ID: 20969559
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microelectrode Recording-Guided Versus Intraoperative Magnetic Resonance Imaging-Guided Subthalamic Nucleus Deep Brain Stimulation Surgery for Parkinson Disease: A 1-Year Follow-Up Study.
    Liu X; Zhang J; Fu K; Gong R; Chen J; Zhang J
    World Neurosurg; 2017 Nov; 107():900-905. PubMed ID: 28842228
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phonemic verbal fluency decline after subthalamic nucleus deep brain stimulation does not depend on number of microelectrode recordings or lead tip placement.
    Smith KM; O'Connor M; Papavassiliou E; Tarsy D; Shih LC
    Parkinsonism Relat Disord; 2014 Apr; 20(4):400-4. PubMed ID: 24495709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.